(Q51161831)

31 March 2018

title

Latent inhibition is unaffected by direct dopamine agonists (English)

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

26 October 2022

author name string

J. Feldon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676170

26 October 2022

A. Shofel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676170

26 October 2022

I. Weiner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676170

26 October 2022

language of work or name

English

0 references

publication date

1 February 1991

1 reference

31 March 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0091305791902838?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

https://api.elsevier.com/content/article/PII:0091305791902838?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Pharmacology, Biochemistry and Behavior

26 October 2022

published in

1 reference

31 March 2018

volume

38

1 reference

31 March 2018

page(s)

309-314

1 reference

31 March 2018

issue

2

1 reference

31 March 2018

Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

The disorder of consciousness in schizophrenia.

26 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Haloperidol enhancement of latent inhibition: Relation to therapeutic action?

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats

26 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Biphasic effect of D-2 agonist quinpirole on locomotion and movements

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

A comparison of the effects of amphetamine, apomorphine and white noise on response switching in the rat.

26 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.

26 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Long-term attentional deficit in nonhandled males: possible involvement of the dopaminergic system

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Behavioral correlations of dopamine receptor activation

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats

26 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Catecholamines and self-stimulation: Evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning

26 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study

26 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Response repetition in pigeons: pharmacological and behavioral specificity.

26 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens

26 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Apomorphine in the evaluation of dopaminergic function in man.

26 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Apomorphine and psychopathology

26 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

A theory of attention: Variations in the associability of stimuli with reinforcement

26 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Behavioural effects of electrolytic and 6-hydroxydopamine lesions of the accumbens and caudate-putamen nuclei.

26 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

The effects of (+)-amphetamine and apomorphine on responding for a conditioned reinforcer.

26 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Major psychosis and dopamine: controversial features and some suggestions

26 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Contrasting interactions of pipradrol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement

26 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

The involvement of dopamine D1 and D2 receptors in the locomotor stimulation produced by (+)-amphetamine in naive and dopamine-depleted mice

26 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors

26 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

26 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems

26 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Facilitation of latent inhibition by haloperidol in rats.

26 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats.

26 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.

26 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.

26 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Disruption of latent inhibition by acute administration of low doses of amphetamine.

26 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats

26 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?

26 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens.

26 October 2022

63

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90283-8

26 October 2022

Identifiers

1 reference

31 March 2018

1 reference

31 March 2018